Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending March 29, 2018. The report serves as a notification regarding the publication of the 2018 Notice of Annual General Meeting (AGM) and the 2017 Annual Summary.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed in this filing. The document focuses solely on corporate governance communications.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary included in this text. The filing confirms that the 2018 AGM Notice and 2017 Annual Summary have been published on the company website and sent to shareholders electing paper communications. The Annual General Meeting is scheduled for Thursday, May 3, 2018, at 2:30 pm at the QEII Centre in London.
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (May 3, 2018, London).
- Access the 2017 Annual Summary and 2018 AGM Notice via the company website or Morningstar UK for detailed financial data.
- Confirm receipt of paper communications if elected as a shareholder.